Cellular Engineering Technologies, Inc.
Methods and processes for manufacturing reproducible human induced pluripotent stem cells (iPSCs) with reduced genetic instability using non-integrating, virus-free, oncogene-free reprogramming and fu
- Sector
- Biotech
- Headquarters
- Coralville, IA
- Latest Form D
- $30K, Feb 2014
- Total capital
- $1.5M
- Federal grants
- $1.4M
- 3 awards · 2020–2021
- 3.0× sector median 1 award
- Private capital raised
- $45K
- 2 Form D · last Feb 2014
- 153 months since last filing
- Federal contracts
- $14K
- 6 awards · Health and Human S, Defense
- Rank in Biotech#378 of 4373
- Granted patents
- 1
- 1 pending · first 2022
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Improving The Reproducibility and Genetic Stability of IPSC and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors$346K
- Federal contractDefense · Amniotic Mesenchymal Stromal Cells$2K
- Federal grantHealth and Human S · Phase II · Improving The Reproducibility and Genetic Stability of IPSC and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors$721K
- Federal grantHealth and Human S · Phase II · Improving The Reproducibility and Genetic Stability of IPSC and Differentiated Cells Through Oncogene-Free Reprogramming and Fully Human Growth Factors$375K
- Federal contractDefense · Amniotic Mesenchymal Stromal Cells$2K
- Federal contractDefense · Amniotic Mesenchymal Stromal Cells$2K
- Federal contractDefense · Amniotic Mesenchymal Stromal Cells$2K
- Private capital raisedForm D · SEC · 2nd filing$30K
- Private capital raisedForm D · SEC · 1st filing$15K
Show 1 earlier federal award
- Federal contractDefense · Amniotic Membrane Mesenchymal Stromal Cells$5K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
1 record has no date or no amount, so it isn’t placed on the timeline.
Standing in Biotech · 4373 companies
Line = median- Federal contracts#378 · top 9%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Alan B MoyResearcherExecutive Officer, DirectorLinked by 1 patent · $1.4M in grants as PI
- Anant B KamathDirectorNamed in SEC Form D filings
- James B MoyDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 2- PendingMethods For Creating Integration-free, Virus-free, Exogenous Oncogene-free Ips Cells And Compositions For Use In Such MethodsUSPTOApplication 17591340
- GrantedMethods For Creating Integration-free, Virus-free, Exogenous Oncogene-free Ips Cells And Compositions For Use In Such MethodsUSPTOUS 11,268,070
Recent research by its founders
- The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy202355 cites
- 210 RNase 7 and the ribonuclease inhibitor regulate RNA-induced inflammatory reactions in keratinocytes20210 cites
- Creating Catholic Regenerative Medicine Organizations in a Secular Biotechnology Field: A Physician-Scientist Experience20190 cites
Related companies, and why
- BioCardia, Inc.Similar federal contract value in Biotech · $15K in contracts
- Guardant HealthSimilar federal contract value in Biotech · $14K in contracts
- PK BIOSCIENCES CORPORATIONSimilar federal contract value in Biotech · $14K in contracts
- MOLECULAR TRANSFER, INC.Similar federal contract value in Biotech · $13K in contracts
- SUPERIOR NANO LLCSimilar federal contract value in Biotech · $12K in contracts
- SPECTRAGENETICSSimilar federal contract value in Biotech · $11K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .